OPC-131461

· Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OPC-131461, covering 2025-10-20 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure [Phase 2]